SMTL ID : 7k8u.1

Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain B: N.331, I.332, Q.580 No protein-ligand interaction detected (PLIP)

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 3 residues within 4Å: Chain A: N.331, P.579, Q.580 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:P.579 Hydrogen bonds: A:N.331 NAG.3: 3 residues within 4Å: Chain C: N.331, P.579, Q.580 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:P.579

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Barnes, C.O. et al., SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature (2020)

Release Date

2020-10-21

Peptides

Spike glycoprotein: ABC
C104 Fab Heavy Chain: D
C104 Fab Light Chain: E

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
H

E
L

Spike glycoprotein

C104 Fab Heavy Chain

C104 Fab Light Chain

Related Entries With Identical Sequence